Merck & Co., Inc. (NYSE:MRK) Gets FDA Nod For ZERBAXA

Donna Fago - June 4, 2019

Merck & Co., Inc. (NYSE:MRK) reported that the U.S. Food and Drug Administration has approved expanded use of its antibiotic to cure hospital-acquired pneumonia in people 18 years and older....

Is Merck & Co., Inc. (NYSE:MRK) Still A Good Buy?

Lisa Ray - October 21, 2013

Boston, MA 10/21/2013 (wallstreetpr) - Merck & Co., Inc. (NYSE:MRK) has been struggling in the first half of 2013 on account of expiration some of the drug patents. It has embarked...

Sign Up To Get Our Latest Stocks Alerts